This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Justice, J. Search for Related Content Social Bookmarking                         What's this?

Phenytoin Monitoring in the Intensive Care Unit

Phenytoin has been used extensively in the neurological and neurosurgical settings since its introduction in 1938. Despite the fact that alternative agents exist, including a whole series of newer agents, phenytoin is still considered one of the most effective, relatively nontoxic anticonvulsant therapies currently available. Unfortunately, however, the pharmacokinetics and pharmacodynamics of this drug are complex and often confuse the pharmacist and physician team, resulting in suboptimal or unacceptably high serum concentrations. This was exactly the case in our institution up until 3 years ago, when a major pharmacy-initiated education and dosing service program was implemented. We review the basic phenytoin monitoring guidelines used in our institution, which are substantiated by the current literature and by personal experience.

Journal of Pharmacy Practice, Vol. 8, No. 1, 29-38 (1995)
DOI: 10.1177/089719009500800104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?